Search hospitals > Montana > Bozeman

Bozeman Deaconess Hospital

Claim this profile
Bozeman, Montana 59715
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Recurrence
Conducts research for Adenocarcinoma
402 reported clinical trials
2 medical researchers
Photo of Bozeman Deaconess Hospital in BozemanPhoto of Bozeman Deaconess Hospital in BozemanPhoto of Bozeman Deaconess Hospital in Bozeman

Summary

Bozeman Deaconess Hospital is a medical facility located in Bozeman, Montana. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Adenocarcinoma and other specialties. Bozeman Deaconess Hospital is involved with conducting 402 clinical trials across 515 conditions. There are 2 research doctors associated with this hospital, such as John M. Schallenkamp and Benjamin T. Marchello.

Area of expertise

1Cancer
Global Leader
Bozeman Deaconess Hospital has run 143 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Bozeman Deaconess Hospital has run 70 trials for Breast Cancer. Some of their research focus areas include:
HER2 negative
Stage IV
ER positive

Top PIs

Clinical Trials running at Bozeman Deaconess Hospital

Breast Cancer
Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Bladder Cancer
Bladder Carcinoma
Prostate Cancer
Rectal Cancer
Colon Cancer
Squamous Cell Carcinoma
Image of trial facility.

Pembrolizumab

for Triple-Negative Breast Cancer

The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Hormone Therapy with or without Radiation

for Breast Cancer

This study is evaluating whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Bozeman Deaconess Hospital?
Bozeman Deaconess Hospital is a medical facility located in Bozeman, Montana. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Adenocarcinoma and other specialties. Bozeman Deaconess Hospital is involved with conducting 402 clinical trials across 515 conditions. There are 2 research doctors associated with this hospital, such as John M. Schallenkamp and Benjamin T. Marchello.
Where is Bozeman Deaconess Hospital located?
**Bozeman Deaconess Hospital Location:** To reach Bozeman Deaconess Hospital, exit I-90 at North 19th Avenue and proceed north. Turn right onto Highland Blvd. The hospital's address is 915 Highland Blvd, Bozeman, MT 59715.
Who should I call to ask about financial aid or insurance network?
Bozeman Deaconess Hospital offers financial assistance and insurance support. For financial assistance, contact the Bozeman Health collection department at 406-414-1015 or mail completed applications to Bozeman Health, Attn: Patient Financial Services, 1600 Ellis St. 3rd Floor, Bozeman, MT 59715. Patients should direct insurance-related inquiries to their providers using the number on their insurance cards; Bozeman Health submits claims, but patients are liable for charges not covered by insurance.
What insurance does Bozeman Deaconess Hospital accept?
Bozeman Health Deaconess Hospital accepts a variety of insurance plans, including Allegiance, Blue Cross Blue Shield, Interwest Health, Medicare, Managed Medicare, Montana Medicaid, Montana United School Trust, New West, United Healthcare, and Work Compensation. The Deaconess Clinic, part of Bozeman Health, also accepts plans from Aetna, Allegiance/Cigna, Blue Cross/Blue Shield, EBMS, Pacific Source, United Healthcare, and Mountain Health Co-op. It is recommended to contact the hospital or clinic directly to confirm coverage for your specific insurance plan.
What awards or recognition has Bozeman Deaconess Hospital received?
Bozeman Deaconess Hospital is renowned for its clinical research, leading to FDA approval of new patient treatments. It also played a pivotal role during the COVID-19 pandemic by collaborating with local universities and suppliers to overcome testing challenges, showcasing its dedication to patient care and community support.